EN HU

Tóth Ágnes

Name: Tóth Ágnes
Affiliation:
  • Debreceni Egyetem. Egészségtudományi Kar. Egészségtudományi Intézet. Integratív Egészségtudományi Tanszék / University of Debrecen. Faculty of Health Sciences. Institute of Health Studies. Integratív Egészségtudományi Tanszék
Other profiles: MTMT
Degree:
  • PhD, DE (2012)

Publication list

2024
1.
Tran, A. T., Ghanem, A. S., Móré, M., Nagy, A. C., Tóth, Á.: Efficacy of Prophylactic Antibiotics in COPD: a Systematic Review.
Antibiotics-Basel. 13 (12), 1-16, (article identifier: 1110), 2024.
Journal metrics:
Q2 Biochemistry (2023)
Q2 Microbiology (medical) (2023)
Q2 Infectious Diseases (2023)
Q2 Microbiology (2023)
D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (2023)
Q1 Pharmacology (medical) (2023)
2022
2.
Mészáros, B., Csóti, Á., Szántó, G. T., Telek, A., Kovács, K., Tóth, Á., Volkó, J., Panyi, G.: The hEag1 K+ Channel Inhibitor Astemizole Stimulates Ca2+ Deposition in SaOS-2 and MG-63 Osteosarcoma Cultures.
Int. J. Mol. Sci. 23 (18), 1-19, 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2020
3.
Papp, F., Hajdu, P., Tajti, G., Tóth, Á., Nagy, É., Fazekas, Z., Kovács, S., Vámosi, G., Varga, Z., Panyi, G.: Periodic Membrane Potential and Ca2+ Oscillations in T Cells Forming an Immune Synapse.
Int. J. Mol. Sci. 21 (5), 1-19, 2020.
Journal metrics:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
2014
4.
Bartók, Á., Tóth, Á., Somodi, S., Szántó, G. T., Hajdu, P., Panyi, G., Varga, Z.: Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Toxicon. 87, 6-16, 2014.
Journal metrics:
Q2 Toxicology
5.
Szalóki, G., Krasznai, Z. T., Tóth, Á., Vízkeleti, L., Szöllősi, A. G., Trencsényi, G., Lajtos, I., Juhász, I., Krasznai, Z., Márián, T., Balázs, M., Szabó, G., Goda, K.: The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity.
PloS ONE. 9 (9), 1-9, 2014.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2010
6.
Hajdu, P., Szilágyi, O., Tóth, Á., Krasznai, Z., Pocsai, K., Panyi, G.: Answer to the "comment on functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse" by Stefan Bittner et al. [Immunol. Lett. 125 (Aug 15 (2)) (2009) 156-157].
Immunol. Lett. 129 (1), 47-49, 2010.
Journal metrics:
Q2 Immunology
Q1 Immunology and Allergy
7.
Krasznai, Z. T., Tóth, Á., Mikecz, P., Fodor, Z., Szabó, G., Galuska, L., Hernádi, Z., Goda, K.: Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.
Eur. J. Pharm. Sci. 41 (5), 665-669, 2010.
Journal metrics:
Q1 Pharmaceutical Science
2009
8.
Mikecz, P., Márián, T., Miklovicz, T., Galuska, L., Krasznai, Z., Tóth, Á., Goda, K., Trón, L., Hernádi, Z., Krasznai, Z. T.: Daunorubicin and doxorubicin inhibit the [(11)C]choline accumulation in cancer cells.
Appl. Radiat. Isot. 67 (10), 1806-1811, 2009.
Journal metrics:
Q2 Radiation
9.
Mikecz, P., Márián, T., Miklovicz, T., Galuska, L., Krasznai, Z., Tóth, Á., Goda, K., Trón, L., Hernádi, Z., Krasznai, Z. T.: Effect of anthracycline derivatives on the [11C]choline and [18f]FDG accumulation in cancer cells.
Nucl. Med. Rev. Cent. East. Eur. 12 (1), 2009.
10.
Tóth, Á., Szilágyi, O., Krasznai, Z., Panyi, G., Hajdu, P.: Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse.
Immunol. Lett. 125 (1), 15-21, 2009.
Journal metrics:
Q2 Immunology
Q1 Immunology and Allergy
11.
Varga, Z., Csépány, T., Papp, F., Fábián, Á. I., Gogolák, P., Tóth, Á., Panyi, G.: Potassium channel expression in human CD4(+) regulatory and naive T cells from healthy subjects and multiple sclerosis patients.
Immunol. Lett. 124 (2), 95-101, 2009.
Journal metrics:
Q2 Immunology
Q1 Immunology and Allergy
DEENK University of Debrecen
© 2012 University of Debrecen